Every Cure Begins With Research.

At USA Health Mitchell Cancer Institute (MCI), our mission is to discover, develop and deliver innovative solutions to improve cancer outcomes. Every breakthrough we make to expand hope is built on advancing knowledge through science.

Research is competitively funded through National Institutes of Health (NIH) and Department of Defense (DOD) grants as well as through state funds, foundations and endowments.

MCI has built a robust, interactive and entrepreneurial training environment where researchers, physicians, physician-scientists, medical students, clinical fellows and Ph.D. graduate students work collaboratively, while supported by state-of-the-art core laboratories and specialized equipment. Current research programs include cancer biology, drug discovery, DNA repair, and cancer cell death and metabolism.

MCI’s newest technological additions are the N-SIM and N-STORM super-resolution microscopes. These cutting-edge technologies combined with our most recent initiatives—the Drug Discovery program and DNA Repair Program—provide our extraordinary team of scientists and researchers with access to some of the most advanced tools in the world.

Through the dedicated work of great minds and innovative technology, as well as our clinical trials patients, we continue to see new breakthroughs that translate into novel diagnostics for early cancer detection and life-saving treatments for cancer patients.” 

News

• USA Health Mitchell Cancer Institute discovers new target in ovarian cancer cells, published in Scientific Reports, a Nature subsidiary   
• USA Health Mitchell Cancer Institute publishes promising immunotherapy research in leading oncology journal   
• USA research, published in Nature, shows how cancer cells exploit the nervous system to spread